Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 488 | 395 | 307 | 265 | 960 |
| Gross Profit | 488 | 395 | 307 | 265 | 960 |
| Operating Expenses | 23,875 | 14,902 | 62,189 | 15,773 | 15,139 |
| Operating Income | -23,387 | -14,507 | -61,882 | -15,508 | -14,179 |
| Other Income | 218 | 206 | 222 | 116 | 85 |
| Pre-tax Income | -23,169 | -14,301 | -61,660 | -15,392 | -14,094 |
| Net Income Continuous | -22,394 | -14,301 | -61,660 | -15,392 | -14,094 |
| Net Income | $-22,394 | $-14,301 | $-61,660 | $-15,392 | $-14,094 |
| EPS Basic Total Ops | -4.60 | -3.50 | -17.60 | -5.70 | -5.50 |
| EPS Basic Continuous Ops | -4.65 | -3.45 | -17.60 | -5.68 | -5.50 |
| EPS Diluted Total Ops | -4.60 | -3.50 | -17.60 | -5.70 | -5.50 |
| EPS Diluted Continuous Ops | -4.65 | -3.45 | -17.60 | -5.68 | -5.50 |
| EBITDA(a) | $-11,700 | $-13,660 | $-12,419 | $-15,188 | $-13,663 |